← SynDRA
DUBERMATINIB
SynDRA canonical compound SYN0029112 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | AURKA | AURKB | AXL |
|---|
| Mechanism of action | AXL kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- AURKA INHIBITOR
- AURKB INHIBITOR
- AXL INHIBITOR
- AXL kinase inhibitor
Cross-references
Synonyms
- TP-0903
- HCl-2084
- TP0903
- TP 0903
- YUAALFPUEOYPNX-UHFFFAOYSA-N
- UNII-14D65TV20J
- CHEMBL2022968
- compound 13
- 14D65TV20J
- 2-((5-chloro-2-((4-((4-methylpiperazin-1-yl)methyl)phenyl)amino)pyrimidin-4-yl)amino)-N,N-dimethylbenzenesulfonamide
- GTPL8863
- SCHEMBL12813478
- EX-A609
- MolPort-039-193-844
- ZINC84617535
- BDBM50382425
- AKOS026750306
- CS-4281
- DA-45909
- HY-12963
- S7846
- FT-0700169
- B5940
- J-690134
- 2-{[5-chloro-2-({4-[(4-methylpiperazin-1-yl)methyl]phenyl}amino)pyrimidin-4-yl]amino}-N,N-dimethylbenzene-1-sulfonamide
- dubermatinibum
- RefChem:135945
- Dubermatinib [USAN]
- MFCD28502172
- DUBERMATINIB [INN]
- Dubermatinib(TP-0903)
- C24H30ClN7O2S
- DUBERMATINIB [WHO-DD]
- orb1306768
- SCHEMBL29394359
- GLXC-90507
- NSC798200
- WHO 10925
- CCG-269819
Look up DUBERMATINIB in the interactive SynDRA portal →